BioSpace News Archive

Jennewein Biotechnologie GmbH announces the introduction of a total biosynthesis approach for the production of human milk oligosaccharides (HMOs).

In the newest rounds of grants marking its 20th anniversary, Hyundai Hope On Wheels celebrates National Childhood Cancer Awareness Month by awarding grants totaling $500,000

Today, Bright Health announced plans to expand upon its Medicare Advantage product offerings with the addition of individual health plans in both Maricopa and Pima counties.

eptune Technologies & Bioressources Inc. (“Neptune” or the “Company”) (NASDAQ: NEPT) (TSX: NEPT) announces that its shareholders have approved at the Annual Meeting of Shareholders held on August 15, 2018, the change of the Company’s legal name to Neptune Wellness Solutions Inc / Neptune Solutions Bien-Être Inc.,

To adapt to rapidly changing industry demands while providing the best possible access to patient care, healthcare organizations are selecting Oracle Cloud Applications.

Dr. Briggs Cook is the Founder and Director of Pure Facial Surgery & Medspa in Huntersville, NC. After graduating summa cum laude with a BA in chemistry from Duke University in 1989, Dr. Cook obtained his Doctor of Medicine from the John Hopkins University School of Medicine in Baltimore, Maryland.

Scientist.com, the life science industry’s leading online marketplace for outsourced research, and the Brain and Spine Institute incubator, iPEPS-ICM, the first innovation accelerator dedicated to brain diseases in France, announced that Cerebrum Therapeutics won a biotech pitch competition with a prize package that includes 6 months free rent at iPEPS’ state-of-the-art facilities located in Paris’ 13th district and $10K USD in research services provided through the Scientist.com marketplace.

Quadrant Biosciences Inc., a developer of novel diagnostic technologies, has been awarded a $2 million Phase II Small Business Technology Transfer (STTR) grant from the National Institutes of Health (NIH) for the refinement and commercialization of an epigenetic autism spectrum disorder (“ASD”) diagnostic test.

IDbyDNA to license the Explify technology platform to Fleury, to perform high quality clinical metagenomic testing within their markets

-According to a report provided by Energias Market Research, the global medical cannabis market is projected to increase in value from USD 8.28 Billion in 2017 to USD 28.07 Billion in 2024 and at a CAGR of 19.1% from 2018 to 2024.